In a rat stroke model, the administration of a Calpain inhibitor mitigated the inflammatory response by suppressing the PARP-NF-κB pathway, which in turn reduced damage to the neurovascular unit and improved neurological function (Yan et al. 2024). The gene discussed is NFKB1; the disease is stroke disorder.